Quick Dispatch:
Your tirzepatide diabetes trial Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide diabetes trial Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial ships.
Need Help?
Questions about tirzepatide diabetes trial Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide diabetes trial Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial in your area.
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice
28.73
FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price
27.85
Tirzepatide for diabetes: on track to SURPASS current therapy
22.85
Diabetes Distilled: “Twincretin” tirzepatide significantly SURPASSes comparator effects on glucose, weight and quality of life
23.97
SURPASS-1 Trial of Tirzepatide in Type 2 Diabetes
23.43
A 3-year study of tirzepatide in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1
24.31
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial
23.12
